Pregabalin Sustained-release Tablets(Jiangsu Hengrui Medicine)

普瑞巴林缓释片(江苏恒瑞医药)

Report date: 2025/08/06 16:42:55

Base Information

Drug NamePregabalin Sustained-release Tablets(Jiangsu Hengrui Medicine)
Drug Alias NamePregabalina普加巴林Pregabalinum普来噶巴林普瑞巴林缓释片(改良型) +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel alpha2/delta subunit 1 blockers
TargetsVoltage-gated calcium channel alpha2/delta subunit 1
Therapy Area/IndicationsPain, PostoperativeNeuralgia, PostherpeticFibromyalgia
Global Approved IndicationsNeuralgia, Postherpetic
Approved Indications in ChinaNeuralgia, Postherpetic
Original Approved Country/TerritoryMainland China
Original Approved Date2021/09/24
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPain, PostoperativeNeuralgia, Postherpetic
Inactive IndicationsFibromyalgia

Other Information

ATC CodeN/A